John R. Mabus

577 total citations
16 papers, 485 citations indexed

About

John R. Mabus is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, John R. Mabus has authored 16 papers receiving a total of 485 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Immunology. Recurrent topics in John R. Mabus's work include Glycosylation and Glycoproteins Research (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Immunodeficiency and Autoimmune Disorders (2 papers). John R. Mabus is often cited by papers focused on Glycosylation and Glycoproteins Research (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Immunodeficiency and Autoimmune Disorders (2 papers). John R. Mabus collaborates with scholars based in United States, Belgium and Canada. John R. Mabus's co-authors include Pamela J. Hornby, Gregory C. Leo, James M. Lenhard, Matthew Jennis, Cassandre Cavanaugh, Zhengyin Yan, Philip Cooper, Jill Giles‐Komar, Gordon Powers and Susan H. Tam and has published in prestigious journals such as Gastroenterology, The FASEB Journal and International Journal of Molecular Sciences.

In The Last Decade

John R. Mabus

16 papers receiving 474 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John R. Mabus United States 11 312 92 86 77 47 16 485
Fatemeh Faramarzi Iran 13 194 0.6× 62 0.7× 115 1.3× 29 0.4× 11 0.2× 33 543
Takuro Matsumoto Japan 12 175 0.6× 15 0.2× 144 1.7× 118 1.5× 28 0.6× 68 516
Mohammad Abolhassani France 13 225 0.7× 11 0.1× 71 0.8× 96 1.2× 11 0.2× 15 554
R. Sergio Solórzano-Vargas United States 14 240 0.8× 39 0.4× 64 0.7× 63 0.8× 4 0.1× 20 650
Wakana Mori Japan 11 160 0.5× 54 0.6× 92 1.1× 33 0.4× 8 0.2× 37 496
Alexey Vanichkin Israel 10 177 0.6× 17 0.2× 115 1.3× 78 1.0× 9 0.2× 17 563
Rashi Rajput Australia 13 174 0.6× 26 0.3× 17 0.2× 46 0.6× 9 0.2× 21 359
D. Biou France 14 254 0.8× 72 0.8× 37 0.4× 50 0.6× 5 0.1× 44 535
Yanjun Liu China 11 315 1.0× 87 0.9× 57 0.7× 14 0.2× 6 0.1× 31 610
Keith W. Ward United States 14 124 0.4× 97 1.1× 72 0.8× 36 0.5× 2 0.0× 19 584

Countries citing papers authored by John R. Mabus

Since Specialization
Citations

This map shows the geographic impact of John R. Mabus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John R. Mabus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John R. Mabus more than expected).

Fields of papers citing papers by John R. Mabus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John R. Mabus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John R. Mabus. The network helps show where John R. Mabus may publish in the future.

Co-authorship network of co-authors of John R. Mabus

This figure shows the co-authorship network connecting the top 25 collaborators of John R. Mabus. A scholar is included among the top collaborators of John R. Mabus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John R. Mabus. John R. Mabus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Jennis, Matthew, Cassandre Cavanaugh, Gregory C. Leo, et al.. (2017). Microbiota‐derived tryptophan indoles increase after gastric bypass surgery and reduce intestinal permeability in vitro and in vivo. Neurogastroenterology & Motility. 30(2). 143 indexed citations
2.
Muzammil, Salman, John R. Mabus, Philip Cooper, et al.. (2016). FcRn binding is not sufficient for achieving systemic therapeutic levels of immunoglobulin G after oral delivery of enteric‐coated capsules in cynomolgus macaques. Pharmacology Research & Perspectives. 4(3). e00218–e00218. 10 indexed citations
3.
Cooper, Philip, Robert A. Perkinson, John R. Mabus, et al.. (2014). The contribution of cell surface FcRn in monoclonal antibody serum uptake from the intestine in suckling rat pups. Frontiers in Pharmacology. 5. 225–225. 13 indexed citations
4.
Mabus, John R., Salman Muzammil, Philip Cooper, et al.. (2014). Enteric‐coated capsule intestinal delivery of human immunoglobulin G in cynomolgus macaques (LB603). The FASEB Journal. 28(S1). 1 indexed citations
5.
Mabus, John R., et al.. (2014). EGF Potentiation of VEGF Production Is Cell Density Dependent in H292 EGFR Wild Type NSCLC Cell Line. International Journal of Molecular Sciences. 15(10). 17686–17704. 10 indexed citations
6.
Mabus, John R., et al.. (2013). Alternative functional in vitro models of human intestinal epithelia. Frontiers in Pharmacology. 4. 79–79. 88 indexed citations
7.
Hornby, Pamela J., Philip Cooper, John R. Mabus, et al.. (2013). FcRn Expression and Antibody Transcytosis in Adult Human and Non‐Human Primate Intestine. The FASEB Journal. 27(S1). 2 indexed citations
8.
Hornby, Pamela J., Philip Cooper, John R. Mabus, et al.. (2013). Human and Non-Human Primate Intestinal FcRn Expression and Immunoglobulin G Transcytosis. Pharmaceutical Research. 31(4). 908–922. 66 indexed citations
9.
Mabus, John R., et al.. (2013). 148 Human Intestinal Epithelium Derived From Induced Pluripotent Stem Cells. Gastroenterology. 144(5). S–33. 1 indexed citations
10.
Hornby, Pamela J., Philip Cooper, John R. Mabus, et al.. (2013). Sa1733 Human and Non-Human Primate Intestinal FcRn Expression and Immunoglobulin Transcytosis. Gastroenterology. 144(5). S–294. 1 indexed citations
11.
Cooper, Philip, Robert A. Perkinson, John R. Mabus, et al.. (2012). Contribution of FcRn binding to intestinal uptake of IgG in suckling rat pups and human FcRn-transgenic mice. American Journal of Physiology-Gastrointestinal and Liver Physiology. 304(3). G262–G270. 26 indexed citations
12.
Codd, Ellen E., et al.. (2011). Dynamic Mass Redistribution as a Means to Measure and Differentiate Signaling via Opioid and Cannabinoid Receptors. Assay and Drug Development Technologies. 9(4). 362–372. 21 indexed citations
13.
Wade, PR, Jeffrey M. Palmer, John R. Mabus, et al.. (2009). Prokineticin-1 evokes secretory and contractile activity in rat small intestine. Neurogastroenterology & Motility. 22(5). e152–61. 13 indexed citations
14.
Lisko, Joseph G., Jeffrey M. Palmer, John R. Mabus, et al.. (2009). Triazinediones as prokineticin 1 receptor antagonists. Part 1: SAR, synthesis and biological evaluation. Bioorganic & Medicinal Chemistry Letters. 19(10). 2661–2663. 10 indexed citations
15.
Hunt, John T., Ving G. Lee, Katerina Leftheris, et al.. (1996). Potent, Cell Active, Non-Thiol Tetrapeptide Inhibitors of Farnesyltransferase. Journal of Medicinal Chemistry. 39(2). 353–358. 65 indexed citations
16.
Sharkey, R M, John R. Mabus, & D M Goldenberg. (1988). Factors influencing anti-antibody enhancement of tumor targeting with antibodies in hamsters with human colonic tumor xenografts.. PubMed. 48(8). 2005–9. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026